Global biopharmaceutical company AstraZeneca has joined hands with Kenya's Ministry of Health to tackle cancer problems facing the country through the unveiling of the Cancer Care Africa programme.
Despite recent increases in resources invested in cancer, several critical barriers still hinder progress, including a lack of disease awareness, limited diagnostic capabilities, an absence of structured screening programmes, and challenges in accessing treatment. Cancer Care Africa has already donated ultrasound biopsy machines to seven hospitals across the country to enhance early prostate cancer diagnosis, as well as donating the country's first biomarker testing machine for epidermal growth factor receptor mutations to Aga Khan University Hospital.